03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Olopat UD : | |
Type | Medicine Authorised |
Originator | G |
Agent | The Lebanese Pharmacists |
Distributor | The Lebanese Pharmacists |
Laboratory | Jamjoum Pharma |
Responsible Party | Jamjoum Pharmaceutical Co |
Origin | KSA |
Manufacturer | Jamjoum Pharmaceuticals |
Manufacturing Type | G |
Origin | KSA |
ATC | S01GX09 |
Olopat UD :
Olopat UD :
Olopat UD :
Olopat UD :
Olopat UD :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abnormal sensation in eye | Common |
Asthenia | Not known |
Blepharospasm | Uncommon |
Conjunctival disorder | Uncommon |
Conjunctival follicles | Uncommon |
Conjunctivitis | Not known |
Corneal deposits | Not known |
Corneal disorder | Uncommon |
Corneal epithelium defect | Uncommon |
Corneal erosion | Uncommon |
Corneal oedema | Not known |
Dermatitis | Not known |
Dermatitis contact | Uncommon |
Dizziness | Uncommon |
Dry eye | Common |
Dry skin | Uncommon |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Common |
Dyspnoea (dyspnea) | Not known |
Erythema | Not known |
Eye discharge | Uncommon |
Eye irritation | Common |
Eye oedema | Not known |
Eye pain | Common |
Eye pruritus | Uncommon |
Eye swelling | Not known |
Eyelid disorder | Uncommon |
Eyelid erythema | Uncommon |
Eyelid margin crusting | Not known |
Eyelid oedema | Uncommon |
Fatigue | Common |
Foreign body sensation in eyes | Uncommon |
Headache | Common |
Hypersensitivity | Not known |
Hypoesthesia | Uncommon |
Keratitis | Uncommon |
Lacrimation increased (Epiphora) | Uncommon |
Malaise | Not known |
Mydriasis (dilated pupils) (Dilatation pupillary) | Not known |
Nasal dryness | Common |
Nausea | Not known |
Ocular discomfort | Uncommon |
Ocular hyperaemia | Uncommon |
Photophobia | Uncommon |
Punctate keratitis | Uncommon |
Rhinitis | Uncommon |
Sinusitis | Not known |
Skin burning sensation | Uncommon |
Somnolence | Not known |
Swelling face | Not known |
Vision blurred | Uncommon |
Visual acuity reduced | Uncommon |
Visual disturbance | Not known |
Vital dye staining cornea present | Uncommon |
Vomiting | Not known |
Olopat UD :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Olopat UD MoH 11657 :
Form | Eye drops, solution in single-dose container |
Packaging | Single-dose containers |
Package Size | 30x0.4ml |
Strength | 0.1% |
Public Price | 1523917.4 L.L. |
Stratum | B |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 54322/1 |
Submission date | 2022 |
Registration Year | 13/06/2024 |
Price Comparison
● Country: | Lebanon | |
● Form: | Eye drops, solution in single-dose container | |
● Package Size: | 30x0.4ml | |
● Public Price: | 1523917.4 LBP | ( 1,523,917.40 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 50797,25 LBP | ( 50,797.00 LBP ) |
● Pricing Date: | 13/06/2024 |
Note
● Cost/Unit: | 50797,25 LBP | ( 50,797.00 LBP ) |
● Cost/Day: | LBP | ( 0.00 LBP ) |
● Cost/Month: | LBP | ( 0.00 LBP ) |
You have to register to view this info
Drop File